Very Brief Exposure for Social Anxiety Disorder
Trial Summary
Yes, participants cannot be on any current psychoactive medication to join this trial.
Research shows that exposure therapy, which is a key part of Very Brief Exposure Therapy, is effective in treating social anxiety disorder. Studies have found that even short-term exposure therapy can lead to improvements in social anxiety symptoms.
12345The research articles reviewed do not provide specific safety data for Very Brief Exposure Therapy, but they suggest that exposure therapy, in general, is considered safe and effective for treating social anxiety disorder.
12356Very Brief Exposure Therapy is unique because it involves shorter, more focused sessions compared to traditional therapies, potentially making it more accessible and less time-consuming for patients while still effectively reducing social anxiety symptoms.
12378Eligibility Criteria
This trial is for transition-age youth with social anxiety disorder (SAD). Participants will be involved in an interview and MRI scans where they'll rate images of facial expressions. Key eligibility details are not provided, so interested individuals should inquire about specific inclusion and exclusion criteria.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Image Exposure
Participants will see various images of facial expressions on a computer screen and provide various rating scores about them.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Participant Groups
Very Brief Exposure is already approved in United States for the following indications:
- Post-traumatic stress disorder (PTSD)